News
Pfizer, Inc. (NYSE:PFE) is one of the high-margin pharma stocks to buy now. Bristol-Myers Squibb Company (NYSE:BMY) and ...
The companies’ new effort would bypass traditional middlemen to cut the drug’s monthly cost from a list price of around $606 ...
Pharmaceutical giants introduce an insurance-free pathway for top anticoagulant Eliquis, following similar direct-to-patient models from Eli Lilly and Novo Nordisk.
These blood thinners may have different effectiveness and safety profiles. Study characteristics We searched scientific databases for clinical trials comparing different blood thinners in people with ...
A large new study from Columbia University is challenging the way many doctors treat high blood pressure. The research suggests that a commonly used drug group—ACE inhibitors—may not be the ...
REGN scores FDA approval for Lynozyfic in tough-to-treat multiple myeloma, bolstering its oncology pipeline amid Eylea headwinds.
Are direct oral anticoagulants (a type of 'blood thinner') better than conventional anticoagulation for treating people with a blood clot in a deep vein?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results